Apimeds Pharmaceuticals US, Inc. - APUS
Detailed investor-level table based on 13F positions.
Methodology:
Market value and % of portfolio use SEC reported VALUE ($000).
For PUT/CALL positions this reflects reported underlying exposure, not premium cash paid/received.
Details.
Rows: 0
| Investor | History | Status | Shares held | Market value ($000) | % of portfolio | Previous % | Rank | Change in shares | % change in shares | Source | Date reported |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Hemenway Trust Co LLC | History | No change | 274,000 | 490 | 0.04% | 0.03% | 1 | 0 | 0.0% | Q1 2026 | May 07, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | History | New | 95,929 | 171 | 0.0% | — | 2 | +95,929 | New | Q1 2026 | May 15, 2026 |
| VANGUARD GROUP INC | History | No change | 58,992 | 96 | 0.0% | 0.0% | 3 | 0 | 0.0% | Q4 2025 | Jan 29, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | History | Added to | 40,051 | 71 | 0.0% | 0.0% | 4 | +5,163 | 14.8% | Q1 2026 | May 15, 2026 |
| VANGUARD FIDUCIARY TRUST CO | History | New | 24,039 | 43 | 0.0% | — | 5 | +24,039 | New | Q1 2026 | May 08, 2026 |
| TWO SIGMA SECURITIES, LLC | History | New | 10,550 | 18 | 0.0% | — | 6 | +10,550 | New | Q1 2026 | May 15, 2026 |
| UBS Group AG | History | Added to | 4,187 | 7 | 0.0% | — | 7 | +3,605 | 619.42% | Q1 2026 | May 05, 2026 |
| JANE STREET GROUP, LLC | History | Closed out | 0 | 0 | — | 0.0% | — | -27,188 | -100.0% | Q1 2026 | May 12, 2026 |
| BANK OF AMERICA CORP /DE/ | History | Closed out | 0 | 0 | — | — | — | -40 | -100.0% | Q1 2026 | May 15, 2026 |
| Tower Research Capital LLC (TRC) | History | Closed out | 0 | 0 | — | — | — | -10 | -100.0% | Q1 2026 | May 15, 2026 |